Description
The overall research objective was to capture and analyze global next-generation (NGS) sequencing trends and use. Most researchers outsource NGS technologies; however, in-house NGS technology use is expected to increase within the next 12 months. Data accuracy and operating costs are the top criteria for purchasing sequencing instruments. Disease-related research is the dominant use for NGS technologies. The popularity of RNA-Seq continues to surge, with half of the respondents planning to use this application in the next 24 months. The most significant bottleneck in the NGS workflow is the length of time spent analyzing data. The in-house annual budget for NGS data interpretation software is more than double that of those who outsource.
Don't have an account? Create One!
Already have an account? Login!
Connect With LinkedIn
Use your Linkedin account to login or register within our store.You're just one click away.